- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.6: 5 residues within 4Å:- Chain A: G.254, L.257, I.258
- Chain E: V.313, V.322
Ligand excluded by PLIPPX4.8: 4 residues within 4Å:- Chain A: F.446, I.450, Y.451, R.455
Ligand excluded by PLIPPX4.9: 2 residues within 4Å:- Chain A: S.329
- Ligands: PX4.10
Ligand excluded by PLIPPX4.10: 5 residues within 4Å:- Chain A: F.326, S.329, I.431, F.436
- Ligands: PX4.9
Ligand excluded by PLIPPX4.11: 1 residues within 4Å:- Chain A: F.339
Ligand excluded by PLIPPX4.14: 5 residues within 4Å:- Chain A: V.313, V.322
- Chain B: G.254, L.257, I.258
Ligand excluded by PLIPPX4.16: 4 residues within 4Å:- Chain B: F.446, I.450, Y.451, R.455
Ligand excluded by PLIPPX4.17: 2 residues within 4Å:- Chain B: S.329
- Ligands: PX4.18
Ligand excluded by PLIPPX4.18: 5 residues within 4Å:- Chain B: F.326, S.329, I.431, F.436
- Ligands: PX4.17
Ligand excluded by PLIPPX4.19: 1 residues within 4Å:- Chain B: F.339
Ligand excluded by PLIPPX4.21: 5 residues within 4Å:- Chain B: V.313, V.322
- Chain C: G.254, L.257, I.258
Ligand excluded by PLIPPX4.23: 4 residues within 4Å:- Chain C: F.446, I.450, Y.451, R.455
Ligand excluded by PLIPPX4.24: 2 residues within 4Å:- Chain C: S.329
- Ligands: PX4.25
Ligand excluded by PLIPPX4.25: 5 residues within 4Å:- Chain C: F.326, S.329, I.431, F.436
- Ligands: PX4.24
Ligand excluded by PLIPPX4.26: 1 residues within 4Å:- Chain C: F.339
Ligand excluded by PLIPPX4.28: 5 residues within 4Å:- Chain C: V.313, V.322
- Chain D: G.254, L.257, I.258
Ligand excluded by PLIPPX4.30: 4 residues within 4Å:- Chain D: F.446, I.450, Y.451, R.455
Ligand excluded by PLIPPX4.31: 2 residues within 4Å:- Chain D: S.329
- Ligands: PX4.32
Ligand excluded by PLIPPX4.32: 5 residues within 4Å:- Chain D: F.326, S.329, I.431, F.436
- Ligands: PX4.31
Ligand excluded by PLIPPX4.33: 1 residues within 4Å:- Chain D: F.339
Ligand excluded by PLIPPX4.34: 4 residues within 4Å:- Chain E: F.446, I.450, Y.451, R.455
Ligand excluded by PLIPPX4.35: 2 residues within 4Å:- Chain E: S.329
- Ligands: PX4.36
Ligand excluded by PLIPPX4.36: 5 residues within 4Å:- Chain E: F.326, S.329, I.431, F.436
- Ligands: PX4.35
Ligand excluded by PLIPPX4.37: 1 residues within 4Å:- Chain E: F.339
Ligand excluded by PLIPPX4.39: 5 residues within 4Å:- Chain D: V.313, V.322
- Chain E: G.254, L.257, I.258
Ligand excluded by PLIP- 5 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
PIO.7: 3 residues within 4Å:- Chain A: L.441, W.448, I.453
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.441, A:W.448
PIO.15: 3 residues within 4Å:- Chain B: L.441, W.448, I.453
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.441, B:W.448
PIO.22: 3 residues within 4Å:- Chain C: L.441, W.448, I.453
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.441, C:W.448
PIO.29: 3 residues within 4Å:- Chain D: L.441, W.448, I.453
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:L.441, D:W.448
PIO.40: 3 residues within 4Å:- Chain E: L.441, W.448, I.453
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:L.441, E:W.448
- 5 x GLY: GLYCINE(Non-covalent)
GLY.12: 3 residues within 4Å:- Chain A: S.162
- Chain E: F.192, Y.235
4 PLIP interactions:1 interactions with chain A, 1 interactions with chain E, 2 Ligand-Ligand interactions- Hydrogen bonds: A:S.162, E:F.192, G.12, G.12
GLY.13: 3 residues within 4Å:- Chain A: F.192, Y.235
- Chain B: S.162
4 PLIP interactions:1 interactions with chain B, 1 interactions with chain A, 2 Ligand-Ligand interactions- Hydrogen bonds: B:S.162, A:F.192, G.13, G.13
GLY.20: 3 residues within 4Å:- Chain B: F.192, Y.235
- Chain C: S.162
4 PLIP interactions:1 interactions with chain B, 1 interactions with chain C, 2 Ligand-Ligand interactions- Hydrogen bonds: B:F.192, C:S.162, G.20, G.20
GLY.27: 3 residues within 4Å:- Chain C: F.192, Y.235
- Chain D: S.162
4 PLIP interactions:1 interactions with chain D, 2 Ligand-Ligand interactions, 1 interactions with chain C- Hydrogen bonds: D:S.162, G.27, G.27, C:F.192
GLY.38: 3 residues within 4Å:- Chain D: F.192, Y.235
- Chain E: S.162
4 PLIP interactions:2 Ligand-Ligand interactions, 1 interactions with chain D, 1 interactions with chain E- Hydrogen bonds: G.38, G.38, D:F.192, E:S.162
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 25 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 5 x PIO: [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate(Non-covalent)
- 5 x GLY: GLYCINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kindig, K. et al., Physiological modulation of alpha3 glycine receptors. To Be Published
- Release Date
- 2024-11-13
- Peptides
- Glycine receptor subunit alpha-3: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.